These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 11499755)
1. Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury model. Wang K; Zhou Z; Zhou X; Tarakji K; Topol EJ; Lincoff AM J Am Coll Cardiol; 2001 Aug; 38(2):577-82. PubMed ID: 11499755 [TBL] [Abstract][Full Text] [Related]
2. Recombinant soluble p-selectin glycoprotein ligand-1-Ig reduces restenosis through inhibition of platelet-neutrophil adhesion after double angioplasty in swine. Bienvenu JG; Tanguay JF; Théorêt JF; Kumar A; Schaub RG; Merhi Y Circulation; 2001 Feb; 103(8):1128-34. PubMed ID: 11222477 [TBL] [Abstract][Full Text] [Related]
3. Prevention of in-stent restenosis via reduction of thrombo-inflammatory reactions with recombinant P-selectin glycoprotein ligand-1. Tanguay JF; Geoffroy P; Sirois MG; Libersan D; Kumar A; Schaub RG; Merhi Y Thromb Haemost; 2004 Jun; 91(6):1186-93. PubMed ID: 15175806 [TBL] [Abstract][Full Text] [Related]
4. Administration of recombinant P-selectin glycoprotein ligand Fc fusion protein suppresses inflammation and neointimal formation in Zucker diabetic rat model. Zhou Z; Penn MS; Forudi F; Zhou X; Tarakji K; Topol EJ; Lincoff AM; Wang K Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1598-603. PubMed ID: 12377736 [TBL] [Abstract][Full Text] [Related]
5. Recombinant soluble P-selectin glycoprotein ligand-Ig (rPSGL-Ig) attenuates infarct size and myeloperoxidase activity in a canine model of ischemia-reperfusion. Wang K; Zhou X; Zhou Z; Tarakji K; Qin JX; Sitges M; Shiota T; Forudi F; Schaub RG; Kumar A; Penn MS; Topol EJ; Lincoff AM Thromb Haemost; 2002 Jul; 88(1):149-54. PubMed ID: 12152656 [TBL] [Abstract][Full Text] [Related]
6. Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model. Kumar A; Villani MP; Patel UK; Keith JC; Schaub RG Circulation; 1999 Mar; 99(10):1363-9. PubMed ID: 10077522 [TBL] [Abstract][Full Text] [Related]
7. rPSGL-1-Ig, a recombinant PSGL-1-Ig fusion protein, ameliorates LPS-induced acute lung injury in mice by inhibiting neutrophil migration. Shao HZ; Qin BY Cell Mol Biol (Noisy-le-grand); 2015 Feb; 61(1):1-6. PubMed ID: 25817339 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the safety of recombinant P-selectin glycoprotein ligand-immunoglobulin G fusion protein in experimental models of localized and systemic infection. Opal SM; Sypek JP; Keith JC; Schaub RG; Palardy JE; Parejo NA Shock; 2001 Apr; 15(4):285-90. PubMed ID: 11303727 [TBL] [Abstract][Full Text] [Related]
9. Recombinant P-selectin glycoprotein-ligand-1 delays thrombin-induced platelet aggregation: a new role for P-selectin in early aggregation. Théorêt JF; Chahrour W; Yacoub D; Merhi Y Br J Pharmacol; 2006 Jun; 148(3):299-305. PubMed ID: 16633357 [TBL] [Abstract][Full Text] [Related]
10. Recombinant P-selectin glycoprotein ligand-1 directly inhibits leukocyte rolling by all 3 selectins in vivo: complete inhibition of rolling is not required for anti-inflammatory effect. Hicks AE; Nolan SL; Ridger VC; Hellewell PG; Norman KE Blood; 2003 Apr; 101(8):3249-56. PubMed ID: 12480716 [TBL] [Abstract][Full Text] [Related]
12. Effect of recombinant soluble P-selectin glycoprotein ligand-1 on leukocyte-endothelium interaction in vivo. Role in rat traumatic shock. Scalia R; Hayward R; Armstead VE; Minchenko AG; Lefer AM Circ Res; 1999 Jan 8-22; 84(1):93-102. PubMed ID: 9915778 [TBL] [Abstract][Full Text] [Related]
13. Soluble P-selectin antagonist mediates rolling velocity and adhesion of leukocytes in acutely inflamed venules. Eppihimer MJ; Schaub RG Microcirculation; 2001 Feb; 8(1):15-24. PubMed ID: 11296849 [TBL] [Abstract][Full Text] [Related]
14. Platelet, not endothelial, P-selectin is required for neointimal formation after vascular injury. Wang K; Zhou X; Zhou Z; Mal N; Fan L; Zhang M; Lincoff AM; Plow EF; Topol EJ; Penn MS Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1584-9. PubMed ID: 15947246 [TBL] [Abstract][Full Text] [Related]
15. CD62 blockade with P-Selectin glycoprotein ligand-immunoglobulin fusion protein reduces ischemia-reperfusion injury after rat intestinal transplantation. Farmer DG; Shen XD; Amersi F; Anselmo D; Ma JP; Ke B; Gao F; Dry S; Fernandez S; Shaw GD; McDiarmid SV; Busuttil RW; Kupiec-Weglinski J Transplantation; 2005 Jan; 79(1):44-51. PubMed ID: 15714168 [TBL] [Abstract][Full Text] [Related]